- Home
- SYNA vs RXRX Comparison
SYNA vs RXRX Comparison
Compare SYNA & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYNA
- RXRX
- Stock Information
- Founded
- SYNA 1986
- RXRX 2013
- Country
- SYNA United States
- RXRX United States
- Employees
- SYNA N/A
- RXRX N/A
- Industry
- SYNA Computer peripheral equipment
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- SYNA Technology
- RXRX Health Care
- Exchange
- SYNA Nasdaq
- RXRX Nasdaq
- Market Cap
- SYNA 2.7B
- RXRX 2.6B
- IPO Year
- SYNA 2002
- RXRX 2021
- Fundamental
- Price
- SYNA $70.08
- RXRX $5.68
- Analyst Decision
- SYNA Strong Buy
- RXRX Buy
- Analyst Count
- SYNA 6
- RXRX 4
- Target Price
- SYNA $90.50
- RXRX $7.25
- AVG Volume (30 Days)
- SYNA 336.6K
- RXRX 70.2M
- Earning Date
- SYNA 11-06-2025
- RXRX 11-05-2025
- Dividend Yield
- SYNA N/A
- RXRX N/A
- EPS Growth
- SYNA N/A
- RXRX N/A
- EPS
- SYNA N/A
- RXRX N/A
- Revenue
- SYNA $1,074,300,000.00
- RXRX $64,596,000.00
- Revenue This Year
- SYNA $11.05
- RXRX $24.17
- Revenue Next Year
- SYNA $11.32
- RXRX $20.96
- P/E Ratio
- SYNA N/A
- RXRX N/A
- Revenue Growth
- SYNA 11.98
- RXRX 30.14
- 52 Week Low
- SYNA $41.80
- RXRX $3.79
- 52 Week High
- SYNA $89.81
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- SYNA 50.69
- RXRX 49.66
- Support Level
- SYNA $69.51
- RXRX $5.58
- Resistance Level
- SYNA $73.05
- RXRX $6.50
- Average True Range (ATR)
- SYNA 2.36
- RXRX 0.56
- MACD
- SYNA 0.09
- RXRX -0.07
- Stochastic Oscillator
- SYNA 66.75
- RXRX 28.91
About SYNA Synaptics Incorporated $0.001 Par Value
Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. It operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products. The company geographically, it derives a majority of revenue from China, and also has its presence in Taiwan, Japan, South Korea, United States and Other countries.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.